Clinical Insights & Research

Radical-7 pulse oximetry masimo down syndrome
Research & Studies Sleep Apnea

New Study Investigates the Use of Home Monitoring to Screen Children with Down Syndrome for Risk of OSA Prior to Multichannel Sleep Studies

Masimo has announced the findings of a recently published study in which researchers investigated whether home pulse oximetry monitoring might be a useful initial screening method of determining which children with Down syndrome (DS) – who are at high risk of obstructive sleep apnea (OSA) – be recommended to undergo […]

Research & Studies

Wake Up Narcolepsy Awards $90,000 To Research

Wake Up Narcolepsy Awards Unrestricted Grants to Stanford And Harvard Narcolepsy Research At the SLEEP 2018 meeting held in early June, Wake Up Narcolepsy awarded Dr. Mignot from Stanford Center for Sleep Sciences and Medicine $45,000 for ongoing research. The funding allows Dr. Mignot to continue his pivotal research into […]

Research & Studies

Supplemental Oxygen Eliminates Morning Blood Pressure Rise in OSA Patients Following CPAP Withdrawal

Supplemental oxygen eliminates the rise in morning blood pressure experienced by obstructive sleep apnea (OSA) patients who stop using continuous positive airway pressure (CPAP), the standard treatment for OSA, according to new research published online in the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine. In “Effect […]

actigraph
Clinical Insights & Research

AASM Publishes Clinical Practice Guideline on Use of Actigraphy for Sleep Disorders

New recommendations for evaluating adult and pediatric patients with suspected sleep-wake disorders Actigraphy can be a useful clinical tool for the evaluation of adult and pediatric patients with suspected sleep disorders, including circadian rhythm sleep-wake disorders, according to a clinical practice guideline from the American Academy of Sleep Medicine (AASM). […]

cannabis
Research & Studies Sleep Apnea

Clinical Trial for Treating OSA Using Cannabinoid-based Drug

Therapix Biosciences Ltd., a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, announced that on June 05, 2018, the first subject was enrolled for its Phase IIa, sponsor-initiated clinical trial using the Company’s cannabinoid-based technology THX-110 for Obstructive Sleep Apnea (OSA), at Assuta Medical Center, the largest […]